3.30

0.30% 0.010

Fortress Biotech Inc (FBIO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt FBIO? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$3.29

Offen:

$3.29

24-Stunden-Volumen:

651.18K

Relative Volume:

1.46

Marktkapitalisierung:

$109.62M

Einnahmen:

$66.16M

Nettoeinkommen (Verlust:

$128.94M

KGV:

1.037

EPS:

3.1823

Netto-Cashflow:

$152.08M

1W Leistung:

+8.55%

1M Leistung:

+19.13%

6M Leistung:

-23.26%

1J Leistung:

+65.83%

1-Tages-Spanne:

$3.13

$3.30

1-Wochen-Bereich:

$2.8729

$3.325

52-Wochen-Spanne:

$1.77

$4.53

Fortress Biotech Inc Stock (FBIO) Company Profile

Firmenname

Fortress Biotech Inc

Sektor

Healthcare (1096)

Branche

Biotechnology (616)

Telefon

781-652-4500

Adresse

1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY

Mitarbeiter

Twitter

@fortressbio

Nächster Verdiensttermin

2026-08-13

Neueste SEC-Einreichungen

FBIO's Discussions on Twitter

Compare FBIO vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
FBIO Fortress Biotech Inc	3.30	109.62M	66.16M	128.94M	152.08M	3.1823
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-03-15	Fortgesetzt	ROTH MKM	Buy
2022-08-04	Eingeleitet	Ladenburg Thalmann	Buy
2020-10-02	Eingeleitet	The Benchmark Company	Buy
2019-12-18	Eingeleitet	B. Riley FBR	Buy
2018-02-28	Eingeleitet	B. Riley FBR, Inc.	Buy
2017-07-11	Eingeleitet	Rodman & Renshaw	Buy
2017-03-22	Eingeleitet	JMP Securities	Mkt Outperform
2016-10-03	Eingeleitet	ROTH Capital	Buy

Alle ansehen

Fortress Biotech Inc Aktie (FBIO) Neueste Nachrichten

Jul 10, 2026

Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) Q1 2026 Earnings: EPS Misses Estimates Significantly, Stock DeclinesEarnings Weakness Phase - dars.gov.et

Jul 10, 2026

Jul 08, 2026

Fortress Biotech highlights its biotech portfolio strategy as a Nasdaq-listed micro-cap - ad-hoc-news.de

Jul 08, 2026

Jul 07, 2026

Mustang Bio (MBIO) Registration Filing Summary - Quartr

Jul 07, 2026

Fortress Biotech focuses on specialty pharma growth and licensing model - ad-hoc-news.de

Jul 07, 2026

Crinetics Pharmaceuticals Acquired by Fortress Biotech for $10 B - GuruFocus

Jul 07, 2026

Technical Reactions to FBIOP Trends in Macro Strategies - Stock Traders Daily

Jul 07, 2026

Jul 06, 2026

Fortress Biotech (FBIO) Slides 2.14% as Selling Pressure Persists Near Support LevelHigh Dividend Factor - dars.gov.et

Jul 06, 2026

Jul 03, 2026

Fortress Biotech Inc highlights its specialty pharma model as investors assess long-term prospects - ad-hoc-news.de

Jul 03, 2026

Jun 26, 2026

Fortress Biotech, Inc. Actuals & Estimates (NASDAQ:FBIO) - TradingView

Jun 26, 2026

Trading the Move, Not the Narrative: (FBIOP) Edition - Stock Traders Daily

Jun 26, 2026

Jun 25, 2026

Fortress Biotech, Inc.9.375% Series A Cumulative Redeemable Perpetual Preferred Stock - TradingView

Jun 25, 2026

FBIO Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Price to sales forward of Fortress Biotech, Inc. – NASDAQ:FBIO - TradingView

Jun 25, 2026

Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes - Yahoo Finance

Jun 25, 2026

Jun 24, 2026

Fortress Biotech (NASDAQ: FBIO) CFO receives 400,000 RSU award - Stock Titan

Jun 24, 2026

Form 4 Fortress Biotech Inc For: 24 June By Investing.com - Investing.com South Africa

Jun 24, 2026

Enterprise value to revenue forward of Fortress Biotech, Inc. – NASDAQ:FBIO - TradingView

Jun 24, 2026

Jun 23, 2026

Fortress Biotech (NASDAQ: FBIO) reports 2026 director and auditor vote tallies - Stock Titan

Jun 23, 2026